Role of protein haptenation in triggering maturation events in the dendritic cell surrogate cell line THP-1

Toxicology and Applied Pharmacology

Volumn 238, Issue 2, 2009, Pages 120-132

  Megherbi, Rym ^a   Kiorpelidou, Evanthia ^a   Foster, Brian ^a   Rowe, Cliff ^a   Naisbitt, Dean J ^a   Goldring, Christopher E ^a   Park, B Kevin ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Contact sensitization; Dendritic cells; Glutathione depletion; Haptenation; THP 1

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; 1 FLUORO 2,4 DINITROBENZENE; CD45 ANTIGEN; DINITROBENZENESULPHONIC ACID; DINITROBROMOBENZENE; DINITROIODOBENZENE; GLUTATHIONE; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; NITROBENZENE DERIVATIVE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANTIGENICITY; ARTICLE; CANCER CELL CULTURE; CELL MATURATION; CHEMOSENSITIZATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; MONOCYTIC LEUKEMIA; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN PHOSPHORYLATION;

ANTIGEN PRESENTATION; CELL LINE, TUMOR; DENDRITIC CELLS; DERMATITIS, ALLERGIC CONTACT; DINITROBENZENES; GLUTATHIONE; HAPTENS; HUMANS; LEUKEMIA, MONOCYTIC, ACUTE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; XENOBIOTICS;

EID: 67349218444     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.05.001     Document Type: Article

References (74)

1. Ade N., Antonios D., Kerdine-Romer S., Boisleve F., Rousset F., and Pallardy M. NF-kappaB plays a major role in the maturation of human dendritic cells induced by NiSO(4) but not by DNCB. Toxicol. Sci. 99 (2007) 488-501
2. Ade N., Leon F., Pallardy M., Peiffer J.L., Kerdine-Romer S., Tissier M.H., et al. HMOX1 and NQO1 genes are upregulated in response to contact sensitizers in dendritic cells and THP-1 cell line: role of the Keap1/Nrf2 pathway. Toxicol. Sci. 107 (2009) 451-460
3. Aiba S., and Katz S.I. Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J. Immunol. 145 (1990) 2791-2796
4. Aiba S., Terunuma A., Manome H., and Tagami H. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur. J. Immunol. 27 (1997) 3031-3038
5. Aiba S., Manome H., Nakagawa S., Mollah Z.U., Mizuashi M., Ohtani T., et al. p38 Mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and 2,4-dinitrochlorobenzene. J. Invest. Dermatol. 120 (2003) 390-399
6. Alvarez-Sanchez R., Basketter D., Pease C., and Lepoittevin J.P. Studies of chemical selectivity of hapten, reactivity, and skin sensitization potency. 3. Synthesis and studies on the reactivity toward model nucleophiles of the 13C-labeled skin sensitizers, 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol-3-one (MI). Chem. Res. Toxicol. 16 (2003) 627-636
7. Alvarez-Sanchez R., Basketter D., Pease C., and Lepoittevin J.P. Covalent binding of the 13C-labeled skin sensitizers 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol-3-one (MI) to a model peptide and glutathione. Bioorg. Med. Chem. Lett. 14 (2004) 365-368
8. Ardeshna K.M., Pizzey A.R., Devereux S., and Khwaja A. The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 96 (2000) 1039-1046
9. Arrighi J.F., Rebsamen M., Rousset F., Kindler V., and Hauser C. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J. Immunol. 166 (2001) 3837-3845
10. Bain J., Plater L., Elliott M., Shpiro N., Hastie C.J., McLauchlan H., et al. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408 (2007) 297-315
11. Basketter D.A., Dearman R.J., Hilton J., and Kimber I. Dinitrohalobenzenes: evaluation of relative skin sensitization potential using the local lymph node assay. Contact Dermatitis 36 (1997) 97-100
12. Becker D., Valk E., Zahn S., Brand P., and Knop J. Coupling of contact sensitizers to thiol groups is a key event for the activation of monocytes and monocyte-derived dendritic cells. J. Invest. Dermatol. 120 (2003) 233-238
13. Brennan P., and O'Neill L.A. Inhibition of nuclear factor kappaB by direct modification in whole cells-mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. Biochem. Pharmacol. 55 (1998) 965-973
14. Bruchhausen S., Zahn S., Valk E., Knop J., and Becker D. Thiol antioxidants block the activation of antigen-presenting cells by contact sensitizers. J. Invest. Dermatol. 121 (2003) 1039-1044
15. Cheng L., Stewart B.J., You Q., Petersen D.R., Ware J.A., Piccotti J.R., et al. Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo. Mol. Pharmacol. 73 (2008) 1769-1775
16. Copple I.M., Goldring C.E., Kitteringham N.R., and Park B.K. The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity. Toxicology 246 (2008) 24-33
17. Coutant K.D., de Fraissinette A.B., Cordier A., and Ulrich P. Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen. Toxicol. Sci. 52 (1999) 189-198
18. Cumberbatch M., Illingworth I., and Kimber I. Antigen-bearing dendritic cells in the draining lymph nodes of contact sensitized mice: cluster formation with lymphocytes. Immunology 74 (1991) 139-145
19. Darley-Usmar V.M., Severn A., O'Leary V.J., and Rogers M. Treatment of macrophages with oxidized low-density lipoprotein increases their intracellular glutathione content. Biochem. J. 278 Pt 2 (1991) 429-434
20. Deneke S.M., and Fanburg B.L. Regulation of cellular glutathione. Am. J. Physiol. 257 (1989) L163-L173
21. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 (1983) 1475-1489
22. Elahi E.N., Wright Z., Hinselwood D., Hotchkiss S.A., Basketter D.A., and Pease C.K. Protein binding and metabolism influence the relative skin sensitization potential of cinnamic compounds. Chem. Res. Toxicol. 17 (2004) 301-310
23. Enk A.H., Angeloni V.L., Udey M.C., and Katz S.I. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. J. Immunol. 150 (1993) 3698-3704
24. Gerberick G.F., Vassallo J.D., Bailey R.E., Chaney J.G., Morrall S.W., and Lepoittevin J.P. Development of a peptide reactivity assay for screening contact allergens. Toxicol. Sci. 81 (2004) 332-343
25. Gerberick F., Aleksic M., Basketter D., Casati S., Karlberg A.T., Kern P., et al. Chemical reactivity measurement and the predicitve identification of skin sensitisers. The report and recommendations of ECVAM Workshop 64. Altern. Lab. Anim. 36 (2008) 215-242
26. Godfrey H.P., and Baer H. The effect of physical and chemical properties of the sensitizing substance on the induction and elicitation of delayed contact sensitivity. J. Immunol. 106 (1971) 431-441
27. Griffith O.W. Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J. Biol. Chem. 257 (1982) 13704-13712
28. Gruenbaum L.M., Schwartz R., Woska Jr. J.R., DeLeon R.P., Peet G.W., Warren T.C., et al. Inhibition of pro-inflammatory cytokine production by the dual p38/JNK2 inhibitor BIRB796 correlates with the inhibition of p38 signaling. Biochem. Pharmacol. 77 (2009) 422-432
29. Han Y., Englert J.A., Yang R., Delude R.L., and Fink M.P. Ethyl pyruvate inhibits nuclear factor-kappaB-dependent signaling by directly targeting p65. J. Pharmacol. Exp. Ther. 312 (2005) 1097-1105
30. Hopkins J.E., Naisbitt D.J., Kitteringham N.R., Dearman R.J., Kimber I., and Park B.K. Selective haptenation of cellular or extracellular protein by chemical allergens: association with cytokine polarization. Chem. Res. Toxicol. 18 (2005) 375-381
31. Hulette B.C., Ryan C.A., Gildea L.A., and Gerberick G.F. Relationship of CD86 surface marker expression and cytotoxicity on dendritic cells exposed to chemical allergen. Toxicol. Appl. Pharmacol. 209 (2005) 159-166
32. Ketterer B., Coles B., and Meyer D.J. The role of glutathione in detoxication. Environ. Health Perspect. 49 (1983) 59-69
33. Kim H.J., Barajas B., Chan R.C., and Nel A.E. Glutathione depletion inhibits dendritic cell maturation and delayed-type hypersensitivity: implications for systemic disease and immunosenescence. J. Allergy Clin. Immunol. 119 (2007) 1225-1233
34. Kitteringham N.R., Powell H., Jenkins R.E., Hamlett J., Lovatt C., Elsby R., et al. Protein expression profiling of glutathione S-transferase pi null mice as a strategy to identify potential markers of resistance to paracetamol-induced toxicity in the liver. Proteomics 3 (2003) 191-207
35. Kuma Y., Sabio G., Bain J., Shpiro N., Marquez R., and Cuenda A. BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo. J. Biol. Chem. 280 (2005) 19472-19479
36. Kuppner M.C., Scharner A., Milani V., Von Hesler C., Tschop K.E., Heinz O., et al. Ifosfamide impairs the allostimulatory capacity of human dendritic cells by intracellular glutathione depletion. Blood 102 (2003) 3668-3674
37. Landsteiner K., and Jacobs J. Studies on the sensitization of animals with simple chemical compounds. II. J. Exp. Med. 64 (1936) 625-639
38. Lopez S., Blanca-Lopez N., Cornejo-Garcia J.A., Canto G., Torres M.J., Mayorga C., et al. Nonimmediate reactions to betalactams. Curr. Opin. Allergy Clin. Immunol. 7 (2007) 310-316
39. Martin E., O'Sullivan B., Low P., and Thomas R. Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity 18 (2003) 155-167
40. Matos T.J., Duarte C.B., Goncalo M., and Lopes M.C. Role of oxidative stress in ERK and p38 MAPK activation induced by the chemical sensitizer DNFB in a fetal skin dendritic cell line. Immunol. Cell Biol. 83 (2005) 607-614
41. Meschkat E., Barratt M.D., and Lepoittevin J. Studies of the chemical selectivity of hapten, reactivity, and skin sensitization potency. 1. Synthesis and studies on the reactivity toward model nucleophiles of the (13)C-labeled skin sensitizers hex-1-ene- and hexane-1,3-sultones. Chem. Res. Toxicol. 14 (2001) 110-117
42. Mitjans M., Viviani B., Lucchi L., Galli C.L., Marinovich M., and Corsini E. Role of p38 MAPK in the selective release of IL-8 induced by chemical allergen in naive THp-1 cells. Toxicol. In Vitro 22 (2008) 386-395
43. Miyazawa M., Ito Y., Kosaka N., Nukada Y., Sakaguchi H., Suzuki H., et al. Role of TNF-alpha and extracellular ATP in THP-1 cell activation following allergen exposure. J. Toxicol. Sci. 33 (2008) 71-83
44. Mizuashi M., Ohtani T., Nakagawa S., and Aiba S. Redox imbalance induced by contact sensitizers triggers the maturation of dendritic cells. J. Invest. Dermatol. 124 (2005) 579-586
45. Moi P., Chan K., Asunis I., Cao A., and Kan Y.W. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 9926-9930
46. Naisbitt D.J., Gordon S.F., Pirmohamed M., Burkhart C., Cribb A.E., Pichler W.J., et al. Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo. Br. J. Pharmacol. 133 (2001) 295-305
47. Natsch A., and Emter R. Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals. Toxicol. Sci. 102 (2008) 110-119
48. Nukada Y., Miyazawa M., Kosaka N., Ito Y., Sakaguchi H., and Nishiyama N. Production of IL-8 in THP-1 cells following contact allergen stimulation via mitogen-activated protein kinase activation or tumor necrosis factor-alpha production. J. Toxicol. Sci. 33 (2008) 175-185
49. Pargellis C., Tong L., Churchill L., Cirillo P.F., Gilmore T., Graham A.G., et al. Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nat. Struct. Biol. 9 (2002) 268-272
50. Parker D., Long P.V., and Turk J.L. A comparison of the conjugation of DNTB and other dinitrobenzenes with free protein radicals and their ability to sensitize or tolerize. J. Invest. Dermatol. 81 (1983) 198-201
51. Pickard C., Smith A.M., Cooper H., Strickland I., Jackson J., Healy E., et al. Investigation of mechanisms underlying the T-cell response to the hapten 2,4-dinitrochlorobenzene. J. Invest. Dermatol. 127 (2007) 630-637
52. Preynat-Seauve O., Coudurier S., Favier A., Marche P.N., and Villiers C. Oxidative stress impairs intracellular events involved in antigen processing and presentation to T cells. Cell Stress Chaperones 8 (2003) 162-171
53. Regan J., Breitfelder S., Cirillo P., Gilmore T., Graham A.G., Hickey E., et al. Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate. J. Med. Chem. 45 (2002) 2994-3008
54. Rodriguez-Pena R., Lopez S., Mayorga C., Antunez C., Fernandez T.D., Torres M.J., et al. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams. J. Allergy Clin. Immunol. 118 (2006) 949-956
55. Rougier N., Redziniak G., Schmitt D., and Vincent C. Evaluation of the capacity of dendritic cells derived from cord blood CD34+ precursors to present haptens to unsensitized autologous T cells in vitro. J. Invest. Dermatol. 110 (1998) 348-352
56. Roychowdhury S., Vyas P.M., Reilly T.P., Gaspari A.A., and Svensson C.K. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes. J. Pharmacol. Exp. Ther. 314 (2005) 43-52
57. Ryan C.A., Kimber I., Basketter D.A., Pallardy M., Gildea L.A., and Gerberick G.F. Dendritic cells and skin sensitization: biological roles and uses in hazard identification. Toxicol. Appl. Pharmacol. 221 (2007) 384-394
58. Saccani S., Pantano S., and Natoli G. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat. Immunol. 3 (2002) 69-75
59. Sakaguchi H., Miyazawa M., Yoshida Y., Ito Y., and Suzuki H. Prediction of preservative sensitization potential using surface marker CD86 and/or CD54 expression on human cell line, THP-1. Arch. Dermatol. Res. 298 (2007) 427-437
60. Sanderson J.P., Naisbitt D.J., Farrell J., Ashby C.A., Tucker M.J., Rieder M.J., et al. Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling. J. Immunol. 178 (2007) 5533-5542
61. Sasaki Y., and Aiba S. Dendritic cells and contact dermatitis. Clin. Rev. Allergy Immunol. 33 (2007) 27-34
62. Schmidt R.J., and Chung L.Y. Biochemical responses of skin to allergenic and non-allergenic nitrohalobenzenes. Evidence that an NADPH-dependent reductase in skin may act as a prohapten-activating enzyme. Arch. Dermatol. Res. 284 (1992) 400-408
63. Scholer A., Hugues S., Boissonnas A., Fetler L., and Amigorena S. Intercellular adhesion molecule-1-dependent stable interactions between T cells and dendritic cells determine CD8+ T cell memory. Immunity 28 (2008) 258-270
64. Shewade Y., Tirth S., and Bhonde R.R. Pancreatic islet-cell viability, functionality and oxidative status remain unaffected at pharmacological concentrations of commonly used antibiotics in vitro. J. Biosci. 26 (2001) 349-355
65. Short S., Merkel B.J., Caffrey R., and McCoy K.L. Defective antigen processing correlates with a low level of intracellular glutathione. Eur. J. Immunol. 26 (1996) 3015-3020
66. Simon J.C., Cruz Jr. P.D., Tigelaar R.E., Sontheimer R.D., and Bergstresser P.R. Adhesion molecules CD11a, CD18, and ICAM-1 on human epidermal Langerhans cells serve a functional role in the activation of alloreactive T cells. J. Invest. Dermatol. 96 (1991) 148-151
67. Steinman R.M., Koide S., Witmer M., Crowley M., Bhardwaj N., Freudenthal P., et al. The sensitization phase of T-cell-mediated immunity. Ann. N. Y. Acad. Sci. 546 (1988) 80-90
68. Tietze C., and Blomeke B. Sensitization assays: monocyte-derived dendritic cells versus a monocytic cell line (THP-1). J. Toxicol. Environ Health A 71 (2008) 965-968
69. Tingle M.D., Clarke J.B., Kitteringham N.R., and Park B.K. Influence of glutathione conjugation on the immunogenicity of dinitrophenyl derivatives in the rat. Int. Arch. Allergy Appl. Immunol. 91 (1990) 160-165
70. Trompezinski S., Migdal C., Tailhardat M., Le Varlet B., Courtellemont P., Haftek M., et al. Characterization of early events involved in human dendritic cell maturation induced by sensitizers: cross talk between MAPK signalling pathways. Toxicol. Appl. Pharmacol. 230 (2008) 397-406
71. Tuschl H., Kovac R., and Weber E. The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals. Toxicol. In Vitro 14 (2000) 541-549
72. Vandeputte C., Guizon I., Genestie-Denis I., Vannier B., and Lorenzon G. A microtiter plate assay for total glutathione and glutathione disulfide contents in cultured/isolated cells: performance study of a new miniaturized protocol. Cell Biol. Toxicol. 10 (1994) 415-421
73. Weltzien H.U., and Padovan E. Molecular features of penicillin allergy. J. Invest. Dermatol. 110 (1998) 203-206
74. Winzen R., Gowrishankar G., Bollig F., Redich N., Resch K., and Holtmann H. Distinct domains of AU-rich elements exert different functions in mRNA destabilization and stabilization by p38 mitogen-activated protein kinase or HuR. Mol. Cell Biol. 24 (2004) 4835-4847